" /> Hepatitis A virus RNA Parvovirus B19 DNA:Imp:Pt:Plas Donor:Ord:Probe.amp.tar - CISMeF





Preferred Label : Hepatitis A virus RNA Parvovirus B19 DNA:Imp:Pt:Plas Donor:Ord:Probe.amp.tar;

LOINC status : ACTIVE;

LOINC display name : HAV RNA Parvovirus B19 DNA NAA probe Ql (P donor) [Interp];

LOINC long common name : Hepatitis A virus RNA Parvovirus B19 DNA [Interpretation] in Plasma from Donor Qualitative by NAA with probe detection;

LOINC short name : HAV RNA B19V DNA Plas Donr NAA probe-Imp;

LOINC description : Simultaneously detects hepatitis A virus (HAV) RNA (genotypes 1-3) and parvovirus B19 (B19) DNA (genotypes 1-3) in human donor plasma, either from whole blood (recovered plasma) or collected by apheresis, prior to further manufacture. The aim is to reduce the B19 burden and remove HAV from plasma pools. This term represents the composite result of the individual HAV qualitative test and B19 quantitative test. If either result is reactive, the composite result is reactive; otherwise, it is nonreactive. Plasma may be tested as individual specimens or in pools. Not intended for use on samples of cord blood or as an aid in diagnosis. This term was created for, but is not limited in use to, the cobas TaqScreen DPX test kit.;

Details


You can consult :


Nous contacter.
07/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.